LETRODGE™ Letrozole Tablets IP 2.5 mg – Aromatase Inhibitor for Breast Cancer Treatment

LETRODGE™ (Letrozole Tablets IP 2.5 mg) is a potent aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, helping to slow or stop the growth of estrogen-dependent tumors.